dronabinol has been researched along with Acute Relapsing Multiple Sclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atamas, SP; Boffa, L; Chintalacharuvu, SR; Chiurchiù, V; Evron, T; Mercuri, NB; Saracini, S; Tiberi, M | 1 |
| Doupe, M; Esfahani, F; Ethans, K; Galloway, K; Gomori, A; Namaka, M; Torabi, M; Turcotte, D | 1 |
| Flachenecker, P | 1 |
| Davies, P; Langford, R; Notcutt, W; Potts, R; Ratcliffe, S | 1 |
1 review(s) available for dronabinol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Evolution of multiple sclerosis spasticity-associated symptoms: latest data.
Topics: Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Plant Extracts; Randomized Controlled Trials as Topic | 2016 |
2 trial(s) available for dronabinol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Double-Blind Method; Dronabinol; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuralgia; Pain Measurement | 2015 |
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).
Topics: Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Muscle Spasticity; Placebos; Plant Extracts; Substance Withdrawal Syndrome | 2012 |
1 other study(ies) available for dronabinol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Apoptosis; Cannabinoid Receptor Agonists; Cell Survival; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Male; Mice; Multiple Sclerosis, Relapsing-Remitting; Receptor, Cannabinoid, CB2; T-Lymphocyte Subsets | 2022 |